| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1423896 | Journal of Controlled Release | 2014 | 13 Pages |
Abstract
The efficacy of pharmaceutical aerosols relates to its deposition in the clinically relevant regions of the lungs, which can be assessed by in vivo lung deposition studies. Dry powder formulations are popular as devices are portable and aerosolisation does not require a propellant. Over the years, key advancements in dry powder formulation, device design and our understanding on the mechanics of inhaled pharmaceutical aerosol have opened up new opportunities in treatment of diseases through pulmonary drug delivery. This review covers these advancements and future directions for inhaled dry powder aerosols.
Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (274 K)Download as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Michael Yifei Yang, John Gar Yan Chan, Hak-Kim Chan,